BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21818889)

  • 21. Development of medicines for children in Europe: ethical implications.
    Saint Raymond A; Brasseur D
    Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better medicines for children--where are we now, and where do we want to be?
    Rose K
    Br J Clin Pharmacol; 2005 Jun; 59(6):657-9. PubMed ID: 15948927
    [No Abstract]   [Full Text] [Related]  

  • 24. Paediatric investigation plans for pain: painfully slow!
    Davies EH; Ollivier CM; Saint Raymond A
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1091-7. PubMed ID: 20821198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Rocchi F; Tomasi P
    Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].
    Riedel C; Lehmann B; Broich K; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Dec; 59(12):1587-1592. PubMed ID: 27778087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
    Seyberth HW; Demotes-Mainard J; Wrobel P
    Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB; Smyth RL
    IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Better medicines for children: European measures].
    van den Berg H; Taminiau JA
    Ned Tijdschr Geneeskd; 2008 Jul; 152(27):1537-40. PubMed ID: 18681365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International pharmaceutical social risk regulation: An ethical perspective.
    Gordon C
    Acta Pharm; 2011 Mar; 61(1):15-23. PubMed ID: 21406340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric clinical trial experience: government, child, parent and physician's perspective.
    Salazar JC
    Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EU's new paediatric medicines legislation: serving children's needs?
    Permanand G; Mossialos E; McKee M
    Arch Dis Child; 2007 Sep; 92(9):808-11. PubMed ID: 17715445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The end of the beginning?
    Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric medicine. Europe follows U.S. in testing drugs for children.
    Bosch X
    Science; 2005 Sep; 309(5742):1799. PubMed ID: 16166486
    [No Abstract]   [Full Text] [Related]  

  • 38. NIHR Medicines for Children Research Network: improving children's health through clinical research.
    Rose AC; Van't Hoff W; Beresford MW; Tansey SP
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):581-7. PubMed ID: 24070097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of drug therapy for children.
    Cohen SN
    Fed Proc; 1977 Sep; 36(10):2356-8. PubMed ID: 892004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.